These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34666791)

  • 1. Long-term remission of AIDS-related primary central nervous system lymphoma in a patient under antiretroviral therapy: a case report and review of the literature.
    Gijs PJ; Clerc O
    AIDS Res Ther; 2021 Oct; 18(1):76. PubMed ID: 34666791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly active antiretroviral therapy as the sole treatment for AIDS-related primary central nervous system lymphoma: a case report with implications for treatment.
    Aboulafia DM; Puswella AL
    AIDS Patient Care STDS; 2007 Dec; 21(12):900-7. PubMed ID: 18154487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Active Antiretroviral Therapy and Gamma Knife Radiosurgery for the Treatment of AIDS-Related Primary Central Nervous System Lymphoma.
    Alvarez-Pinzon AM; Valerio JE; Swedberg HN; Elwasila SM; Wolf A; Alonso JR
    World Neurosurg; 2019 Apr; 124():310-312. PubMed ID: 30654158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
    González-Aguilar A; Soto-Hernández JL
    Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma.
    Skiest DJ; Crosby C
    AIDS; 2003 Aug; 17(12):1787-93. PubMed ID: 12891064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival in AIDS-related primary central nervous system lymphoma.
    Gupta NK; Nolan A; Omuro A; Reid EG; Wang CC; Mannis G; Jaglal M; Chavez JC; Rubinstein PG; Griffin A; Abrams DI; Hwang J; Kaplan LD; Luce JA; Volberding P; Treseler PA; Rubenstein JL
    Neuro Oncol; 2017 Jan; 19(1):99-108. PubMed ID: 27576871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of HIV-related primary central nervous system lymphoma with AZT high dose, HAART, interleukin-2 and foscarnet in three patients.
    Marretta L; Stocker H; Drauz D; Mueller M; Masuhr A; Dieckmann S; Wong V; Koch A; Grueneisen A; Arastéh K; Weiss R
    Eur J Med Res; 2011 May; 16(5):197-205. PubMed ID: 21719392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
    Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
    J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
    Cingolani A; Fratino L; Scoppettuolo G; Antinori A
    J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019.
    Aboulafia DM; Ratner L; Miles SA; Harrington WJ;
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):399-402. PubMed ID: 16640817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era.
    Nagai H; Odawara T; Ajisawa A; Tanuma J; Hagiwara S; Watanabe T; Uehira T; Uchiumi H; Yotsumoto M; Miyakawa T; Watanabe A; Kambe T; Konishi M; Saito S; Takahama S; Tateyama M; Okada S
    Eur J Haematol; 2010 Jun; 84(6):499-505. PubMed ID: 20132301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery.
    Hoffmann C; Tabrizian S; Wolf E; Eggers C; Stoehr A; Plettenberg A; Buhk T; Stellbrink HJ; Horst HA; Jäger H; Rosenkranz T
    AIDS; 2001 Nov; 15(16):2119-27. PubMed ID: 11684931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
    Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
    Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
    de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
    Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
    Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
    Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy.
    Moulignier A; Lamirel C; Picard H; Lebrette MG; Amiel C; Hamidi M; Polivka M; Mikol J; Cochereau I; Pialoux G
    Neurology; 2017 Aug; 89(8):796-804. PubMed ID: 28747447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.